BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pennisi M, Russo G, Di Salvatore V, Candido S, Libra M, Pappalardo F. Computational modeling in melanoma for novel drug discovery. Expert Opin Drug Discov 2016;11:609-21. [PMID: 27046143 DOI: 10.1080/17460441.2016.1174688] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Enewold L, Sharon E, Harlan LC. Metastatic Melanoma: Treatment and Survival in the US after the Introduction of Ipilimumab and Vemurafenib. Oncol Res Treat 2017;40:174-83. [PMID: 28376479 DOI: 10.1159/000456014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
2 Pennisi M, Russo G, Ravalli S, Pappalardo F. Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus. BMC Bioinformatics 2017;18:544. [PMID: 29297294 DOI: 10.1186/s12859-017-1961-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
3 Meng L, Huang Z. In silico-in vitro discovery of untargeted kinase-inhibitor interactions from kinase-targeted therapies: A case study on the cancer MAPK signaling pathway. Comput Biol Chem 2018;75:196-204. [PMID: 29803964 DOI: 10.1016/j.compbiolchem.2018.05.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
4 Matias M, Pinho JO, Penetra MJ, Campos G, Reis CP, Gaspar MM. The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval. Cells 2021;10:3088. [PMID: 34831311 DOI: 10.3390/cells10113088] [Reference Citation Analysis]
5 Cordaro FG, De Presbiteris AL, Camerlingo R, Mozzillo N, Pirozzi G, Cavalcanti E, Manca A, Palmieri G, Cossu A, Ciliberto G, Ascierto PA, Travali S, Patriarca EJ, Caputo E. Phenotype characterization of human melanoma cells resistant to dabrafenib. Oncol Rep 2017;38:2741-51. [PMID: 29048639 DOI: 10.3892/or.2017.5963] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
6 Yousuf Y, Amini-nik S, Jeschke MG. Overall perspective on the clinical importance of skin models. Skin Tissue Models for Regenerative Medicine. Elsevier; 2018. pp. 39-54. [DOI: 10.1016/b978-0-12-810545-0.00002-4] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Cova TFGG, Bento DJ, Nunes SCC. Computational Approaches in Theranostics: Mining and Predicting Cancer Data. Pharmaceutics 2019;11:E119. [PMID: 30871264 DOI: 10.3390/pharmaceutics11030119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
8 Sylman JL, Mitrugno A, Atallah M, Tormoen GW, Shatzel JJ, Tassi Yunga S, Wagner TH, Leppert JT, Mallick P, McCarty OJT. The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis. Front Oncol 2018;8:78. [PMID: 29619344 DOI: 10.3389/fonc.2018.00078] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
9 Moradi Kashkooli F, Soltani M, Souri M, Meaney C, Kohandel M. Nexus between in silico and in vivo models to enhance clinical translation of nanomedicine. Nano Today 2021;36:101057. [DOI: 10.1016/j.nantod.2020.101057] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 12.0] [Reference Citation Analysis]
10 Hon KL, Lee VW. Challenges for drug discovery and development in China. Expert Opin Drug Discov 2017;12:105-13. [PMID: 27808589 DOI: 10.1080/17460441.2017.1257115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
11 Wang C, Xu P, Zhang L, Huang J, Zhu K, Luo C. Current Strategies and Applications for Precision Drug Design. Front Pharmacol 2018;9:787. [PMID: 30072901 DOI: 10.3389/fphar.2018.00787] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
12 Leonardi GC, Falzone L, Salemi R, Zanghì A, Spandidos DA, Mccubrey JA, Candido S, Libra M. Cutaneous melanoma: From pathogenesis to therapy (Review). Int J Oncol 2018;52:1071-80. [PMID: 29532857 DOI: 10.3892/ijo.2018.4287] [Cited by in Crossref: 87] [Cited by in F6Publishing: 109] [Article Influence: 21.8] [Reference Citation Analysis]
13 Viceconti M, Pappalardo F, Rodriguez B, Horner M, Bischoff J, Musuamba Tshinanu F. In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products. Methods 2021;185:120-7. [PMID: 31991193 DOI: 10.1016/j.ymeth.2020.01.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]